Get notified when NRIX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: NRIX Nurix Therapeutics, Inc. 8-K

Nurix Therapeutics reports Q3 FY2026 financial results for quarter ended February 28

Filed April 8, 2026 · Period ending April 8, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release announcing financial results for the fiscal quarter ended February 28, 2026. Actual financial figures are contained in the attached press release, not in the 8-K body itself.

    Item 7.01 view on EDGAR →
  • low

    This is a standard quarterly earnings announcement filing. The 8-K serves as a procedural wrapper for the press release (Exhibit 99.1) containing the actual financial data.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.

Partner

Trade NRIX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify